T cells that can recognise viral proteins presented by MHC at an early stage of viral infection, before de novo production of virions, might have a protective advantage in SARS-CoV-2 infection by limiting viral spread or even by causing an abortive infection. This evidence concerns the gene HLA-C and infection.